Refine by
Hipaa Compliance Articles & Analysis
22 news found
Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV: HEM, OTCQB: HMTXF; FSE:2VF0), the leading autologous (patient’s own) stem cell therapy company treating no-option patients in Florida suffering in pain from Chronic Limb Threatening Ischemia, Peripheral Arterial Disease and Angina, is pleased to announce its webinar topic for Thursday, August 21, 2025. Croom ...
Bodyport, a biomarker-guided digital therapeutics company on a mission to address complex chronic conditions, announced today the appointment of Jim Pursley to the company’s board of directors. “I am excited to join the Bodyport Board of Directors as they reimagine care for patients living with complex chronic conditions. Bodyport’s focus on the patient has driven them to ...
Adhesive patches are limited by skin irritation, compliance, and are most useful for monitoring over short time periods ( We believe there is a clear need for non-invasive, user-friendly, affordable, and scalable solutions, validated with rigorous clinical evidence of their effectiveness. ...
Bodyport, a biomarker-guided digital therapeutics company on a mission to address complex chronic conditions, today announced the appointment of medtech industry veteran, John Lipman, as Chief Executive Officer. Bodyport co-founder, Corey Centen, will continue as President and also serve as Chief Technology Officer (CTO) of the company. Lipman’s appointment comes as Bodyport prepares for ...
Today, at the annual meeting of the American Society of Clinical Oncology (ASCO), Prognos Health and xCures announced a collaboration to enable real-world data access and insights for life science companies across multiple use cases. The multi-year agreement will enable linking and access to xCures de-identified data and Prognos healthcare data marketplace. “We are excited about combining ...
ByxCures
SOMERVILLE, Mass., March 24, 2022 — Podimetrics, creator of the FDA-cleared SmartMat™ and integrated clinical care services that can help save the limbs and lives of complex patients with diabetes, today announced a $45 million Series C round led by D1 Capital Partners, along with two new investors, the Medtech Convergence Fund and an undisclosed strategic investor. Existing ...
Deep Lens, a digital healthcare company focused on revolutionizing the oncology clinical trial recruitment process through artificial intelligence solutions, today announced the launch of its Real Time Feasibility offering, a new HIPAA-compliant tool designed to identify eligible patients and select the most effective sites in the Deep Lens Unity Network for oncology clinical trials in real-time. ...
Once a referral is received, the Monitoring Center manages everything from benefit verification, patient engagement, device provisioning and training to compliance monitoring and alert notification. Patients perform a short, daily test on an easy-to-use device and their results are automatically transmitted to the Monitoring Center. ...
We have since expanded our range, with remote patient monitoring kits that measure things including blood pressure, heart rate, temperature, blood glucose and patient compliance. The RPM kits add valuable real-time data to the ability to remotely connect physicians and their patients, providing a more comprehensive portrait of a patient’s health. When patients are given ...
Investigational Medicinal Products (IMP) and non-IMP drugs are shipped directly to patients' homes from either a pharmacy or central depot site using a GMP-compliant clinical supply chain system and coordinated through Thermo Fisher's HIPAA- and GDPR-compliant Direct-to-Patient contact center and Patheon Logistics. The Clinical Site-to-Patient service leverages Thermo Fisher's ...
MedTech Innovator, the largest accelerator of medical devices in the world, today announced the finalists for MedTech Innovator’s eighth annual competition: Cellvie, Circadia Health, Lief Therapeutics, Moray Medical, and Rhaeos. Virtual attendees of The MedTech Conference, the largest gathering of medtech industry leaders in North America, powered by AdvaMed, will vote online to choose the ...
Electroencephalography (EEG) devices are incredibly helpful in diagnosing and monitoring certain brain disorders, such as epilepsy and strokes. However, they are not particularly user-friendly or convenient, with specialized technicians performing time consuming procedures, such as skin preparation, to get patients ready to undergo the procedure. A combination of messy gels and wires also makes ...
RemetricHealth, a leading remote patient monitoring (RPM) and telehealth services company that has been serving the healthcare industry for more than a decade, has announced that its telehealth capabilities, in conjunction with its biometric monitoring devices, are helping connect patients and providers in a time when continuity of care can be challenging due to COVID-19. The telehealth model is ...
IRVINE, Calif., May 28, 2020 (Newswire.com) - betweenMD is very excited to announce our partnership with Oxitone, makers of the world's first FDA-cleared risk monitoring device. Oxitone developed a wearable monitoring device, specifically designed and FDA-cleared for in-home use for patients with respiratory failure. This unique solution is for prolonged monitoring for those at risk for ...
We deeply thank you for the service you do for the society and for the essential care you provide to pregnant mothers across the US amid this unprecedented pandemic. Our hearts and thoughts go to all of you–you and your family, your clinic staff members, your patients–who have been affected by COVID-19. As a fellow healthcare provider, our team shares the concerns that many of you are ...
Additionally, Accsense features electronic documentation to help your institution achieve regulatory compliance with HIPAA, JCAHO, and other patient confidentiality demands. ...
Additionally, the company received certification that its Quality System is in compliance with ISO 13485 for design, development, marketing and sales of image processing software and accessories for estimation and monitoring of external blood loss. ...
Gauss Surgical, Inc. announced today that the company will compete in the annual “UHC Startup Challenge”, which will take place on Friday, October 2 in Orlando as part of the “Advance: UHC Annual Conference 2015”. The company will have the opportunity to present Triton, the world’s first and only mobile platform for real-time monitoring of surgical blood loss, to the ...
Gauss Surgical, Inc. announced today that the company has completed series A financing to accelerate sales growth and further commercialization of the Triton System™, the world’s first and only mobile platform for real-time monitoring of surgical blood loss. The latest round was led by Promus Ventures and joined by Summation Health Ventures and LifeForce Ventures. “As prior ...
Gauss Surgical today announced that the company has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Triton Canister App, the second core product in its Triton System™ portfolio, the world’s first and only mobile platform for real-time monitoring of surgical blood loss. Now, in addition to estimating blood loss on surgical sponges, the system can accurately ...